Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Cantor Fitzgerald
US Department of Justice
Julphar
Baxter
AstraZeneca
Cipla
McKesson

Generated: August 15, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl, and when can generic versions of Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl launch?

Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl is a drug marketed by Barr and is included in one NDA.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Drug patent expirations by year for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Pharmacology for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

US Patents and Regulatory Information for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062759-001 May 20, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
McKinsey
UBS
US Department of Justice
Express Scripts
Healthtrust
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.